In recent years, many scholars have focused on the prediction of BCR in prostate cancer, hoping to know the BCR probability of patients earlier so as to achieve early prevention, early diagnosis, and early treatment and to have achieved certain results [10,11,12,13]. This evidence concerns the gene BCR and prostate carcinoma.